Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2010-02-25
2011-11-29
Kosar, Andrew D (Department: 1622)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C548S300400
Reexamination Certificate
active
08067454
ABSTRACT:
A series of novel thio-substituted anthra[1,2-d]imidazole-6,11-dione derivatives, and the preparation method and application of said derivatives, said application having a pharmaceutical composition containing said derivatives with therapeutically effective amount for treating cancer, and said application involves effects of said derivatives for inhibiting telomerase activity, inhibiting the growth of cancer cell, treating cancer and the like.
REFERENCES:
Golub et al., Molecular Classification of Cancer: Class Discovery and Class Prediction by Gene Expression Monitoring, Science, vol. 286, Oct. 15, 1999, p. 531-537.
Targeted Cancer Therapies, http://www.cancer.gov/cancertopics/factsheet/therapy/targeted, accessed Jan. 12, 2011.
Bel-Ghacham, Synthesis and complexing properties of new polyether heterocycles containing anthraquinonic sulfur system, 2008, Journal Marocain de Chimie Heterocyclique, vol. 7, No. 1, p. 62-69.
Cheng Karen
Kosar Andrew D
Muncy Geissler Olds & Lowe, PLLC
National Defense Medical Center
LandOfFree
Thio-substituted Anthra [1, 2-d] imidazole- 6, 11-dione... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Thio-substituted Anthra [1, 2-d] imidazole- 6, 11-dione..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Thio-substituted Anthra [1, 2-d] imidazole- 6, 11-dione... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4258654